Purapharm Corp. Ltd. | Cash Flow
Fiscal year is January-December. All values HKD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
29,690.00
42,330.00
40,134.00
38,667.00
10,331.00
26,531
Depreciation, Depletion & Amortization
12,045.00
13,663.00
13,227.00
16,541.00
26,836.00
37,296
Other Funds
2,749.00
4,319.00
7,330.00
2,020.00
21,209.00
20,624
Funds from Operations
38,986.00
51,674.00
46,031.00
53,188.00
15,958.00
43,203
Changes in Working Capital
41,061.00
33,655.00
68,844.00
118,347.00
77,655.00
5,924
Net Operating Cash Flow
2,075.00
18,019.00
22,813.00
65,159.00
61,697.00
49,127
Capital Expenditures
18,808.00
11,343.00
33,081.00
60,208.00
124,552.00
Sale of Fixed Assets & Businesses
132.00
457.00
1,164.00
-
744.00
Purchase/Sale of Investments
24,594.00
487.00
3,028.00
-
9,551.00
Net Investing Cash Flow
6,268.00
24,634.00
59,393.00
60,208.00
295,101.00
Cash Dividends Paid - Total
-
-
-
19,936.00
4,942.00
Issuance/Reduction of Debt, Net
3,308.00
8,947.00
52,948.00
141,987.00
228,066.00
Net Financing Cash Flow
3,308.00
21,053.00
261,979.00
112,032.00
223,124.00
Net Change in Cash
3,987.00
13,884.00
170,874.00
18,114.00
124,324.00
Free Cash Flow
19,262.00
9,433.00
51,228.00
106,443.00
163,325.00
Net Assets from Acquisitions
-
-
-
-
161,742.00
Other Sources
5,676.00
4,067.00
494.00
-
-
Change in Capital Stock
-
30,000.00
314,927.00
10,019.00
-
Exchange Rate Effect
1,048.00
554.00
8,899.00
4,779.00
9,350.00
Other Uses
17,862.00
17,328.00
24,942.00
-
-
About Purapharm Corp.
View Profile
